Workflow
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation
GlobeNewswire·2025-05-15 20:32

3MillionLeadOrderfromStrategicInvestorsSupportsBoldTransformationVANCOUVER,BritishColumbia,May15,2025(GLOBENEWSWIRE)−−RakovinaTherapeuticsInc.(TSX−V:RKV)(FSE:7JO)(“Rakovina”orthe“Company”),abiopharmaceuticalcompanyadvancinginnovativecancertherapiesthroughartificialintelligence(AI)−powereddrugdiscovery,todayannouncesastrategicfinancingofapproximately3 Million Lead Order from Strategic Investors Supports Bold TransformationVANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announces a strategic financing of approximately 4 million (the “Offering”) consisting of concurrent private placements of (i) convertible debenture units (“De ...